{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:49:15Z","timestamp":1778680155306,"version":"3.51.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00059-012-3720-z","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T16:02:05Z","timestamp":1354723325000},"page":"880-886","source":"Crossref","is-referenced-by-count":16,"title":["Diabetic cardiomyopathy: ongoing controversies in 2012","Diabetische Kardiomyopathie: aktuelle Kontroversen 2012"],"prefix":"10.1007","volume":"37","author":[{"given":"P.M.","family":"Seferovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Milinkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.","family":"Risti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Seferovi\u0107 Mitrovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lali\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Joti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Kanjuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Lali\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Maisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,5]]},"reference":[{"key":"3720_CR1","unstructured":"Consentino F, Ryden L, Francia P (2006) Diabetes mellitus and metabolic syndrome. In: Camm AJ, Luscher TF, Serruys PW (eds) The ESC Textbook of cardiovascular medicine, Blackwell, London, p\u00a0301\u2013331"},{"key":"3720_CR2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/eurheartj\/ehm124","volume":"28","author":"Ryden","year":"2007","unstructured":"Ryden L, Standl E, Bartnik M et al (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28(1):88\u2013136","journal-title":"Eur Heart J"},{"key":"3720_CR3","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","volume":"241","author":"Kannel","year":"1979","unstructured":"Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease: the Framingham study. JAMA 241:2035\u20132038","journal-title":"JAMA"},{"key":"3720_CR4","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","volume":"103","author":"Iribarren","year":"2001","unstructured":"Iribarren C, Karter AJ, Go AS et al (2001) Glycemic control and heart failure among adult patients with diabetes. Circulation 103:2668\u20132673","journal-title":"Circulation"},{"key":"3720_CR5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diacare.29.03.06.dc05-1501","volume":"29","author":"Bertoni","year":"2006","unstructured":"Bertoni AG, Goff DC Jr, D\u2019Agostino RB Jr et al (2006) Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 29(3):588\u2013594","journal-title":"Diabetes Care"},{"key":"3720_CR6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ et al (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595\u2013602","journal-title":"Am J Cardiol"},{"key":"3720_CR7","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.2337\/diacare.26.10.2949","volume":"26","author":"Bell","year":"2003","unstructured":"Bell DSH (2003) Diabetic cardiomyopathy. Diabetes Care 26:2949\u20132951","journal-title":"Diabetes Care"},{"key":"3720_CR8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"Elliott","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29(2):270\u2013276","journal-title":"Eur Heart J"},{"key":"3720_CR9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/CIRCHEARTFAILURE.108.770826","volume":"1","author":"Maron","year":"2008","unstructured":"Maron BJ (2008) Controversies in heart failure. The 2006 American Heart Association classification of cardiomyopathies is the gold standard. Circ Heart Fail 1:72\u201376","journal-title":"Circ Heart Fail"},{"key":"3720_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"Boudina","year":"2010","unstructured":"Boudina S, Abel ED (2010) Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11:31\u201339","journal-title":"Rev Endocr Metab Disord"},{"key":"3720_CR11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00059-011-3429-4","volume":"36","author":"Maisch","year":"2011","unstructured":"Maisch B, Alter P, Pankuweit S (2011) Diabetic cardiomyopathy-fact or fiction. Herz 36:102-117","journal-title":"Herz"},{"key":"3720_CR12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.beem.2008.10.016","volume":"23","author":"Khavandi","year":"2009","unstructured":"Khavandi K, Khavandi A, Asghar O et al (2009) Diabetic cardiomyopathy-a distinct disease? Best Pract Res Clin Endocrinol Metab 23(3):347\u2013360","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3720_CR13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0735-1097(02)02869-3","volume":"41","author":"Fang","year":"2003","unstructured":"Fang ZY, Yuda S, Anderson V et al (2003) Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 41:611\u2013617","journal-title":"J Am Coll Cardiol"},{"key":"3720_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1096-9136(199604)13:4<321::AID-DIA3>3.0.CO;2-7","volume":"13","author":"Di","year":"1996","unstructured":"Di Bonito P, Cuomo S, Moio N et al (1996) Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration. Diabet Med 13:321\u2013324","journal-title":"Diabet Med"},{"key":"3720_CR15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","volume":"289","author":"Redfield","year":"2003","unstructured":"Redfield MM, Jacobsen SJ, Burnett JC et al (2003) Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 289:194\u2013202","journal-title":"JAMA"},{"key":"3720_CR16","first-page":"219","volume":"156","author":"Seferovic","year":"2012","unstructured":"Seferovic Mitrovic JP, Seferovic PM, Vujisic Te\u0161ic B et al (2012) Predictors of diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes. In J Cardiol 156:219\u2013221","journal-title":"In J Cardiol"},{"key":"3720_CR17","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","volume":"28","author":"Paulus","year":"2007","unstructured":"Paulus WJ, Tsch\u00f6pe C, Sanderson JE et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539\u20132550","journal-title":"Eur Heart J"},{"key":"3720_CR18","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0140-6736(02)08358-7","volume":"359","author":"Struthers","year":"2002","unstructured":"Struthers AD, Morris AD (2002) Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet 359:1430\u20131432","journal-title":"Lancet"},{"key":"3720_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0008-6363(98)00186-2","volume":"40","author":"Dhalla","year":"1998","unstructured":"Dhalla NS, Liu X, Panagia V, Takeda N (1998) Subcellular remodelling and heart dysfunction in chronic diabetes. Cardiovasc Res 40:239\u2013247","journal-title":"Cardiovasc Res"},{"key":"3720_CR20","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1210\/jc.83.12.4284","volume":"83","author":"Phillips","year":"1998","unstructured":"Phillips RA, Krakoff LR, Dunaif A et al (1998) Relation among left ventricular mass, insulin resistance and blood pressure in non obese subjects. J Clin Endocrinol Metab 83:4284\u20134288","journal-title":"J Clin Endocrinol Metab"},{"key":"3720_CR21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm1000","volume":"10","author":"Braz","year":"2004","unstructured":"Braz JC, Gregory K, Pathak A et al (2004) PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nature Medicine 10(3):248\u2013254","journal-title":"Nature Medicine"},{"key":"3720_CR22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.amjmed.2008.03.046","volume":"121","author":"Aneja","year":"2008","unstructured":"Aneja A, Tang WH, Bansilal S et al (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121:748\u2013757","journal-title":"Am J Med"},{"key":"3720_CR23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/hrt.2005.068270","volume":"93","author":"Seddon","year":"2007","unstructured":"Seddon M, Looi YH, Shah AM (2007) Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93(8):903\u2013907","journal-title":"Heart"},{"key":"3720_CR24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yjmcc.2008.06.009","volume":"45","author":"Chiu","year":"2008","unstructured":"Chiu J, Farhangkhoee H, Xu BY et al (2008) PARP mediates structural alterations in diabetic cardiomyopathy. J Mol Cell Cardiol 45(3):385\u2013393","journal-title":"J Mol Cell Cardiol"},{"key":"3720_CR25","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2337\/diabetes.50.10.2363","volume":"50","author":"Fiordaliso","year":"2001","unstructured":"Fiordaliso F, Leri A, Cesselli D et al (2001) Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50:2363\u20132375","journal-title":"Diabetes"},{"key":"3720_CR26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.abb.2003.09.005","volume":"420","author":"Argirova","year":"2003","unstructured":"Argirova MD, Ortwerth BJ (2003) Activation of protein-bound copper ions during early glycation: study on two proteins. Arch Biochem Biophys 420:176\u2013184","journal-title":"Arch Biochem Biophys"},{"key":"3720_CR27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/01.CIR.0000045671.62860.98","volume":"107","author":"Rutter","year":"2003","unstructured":"Rutter MK, Parise H, Benjamin EJ et al (2003) Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107:448\u2013454","journal-title":"Circulation"},{"key":"3720_CR28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/dmrr.1063","volume":"26","author":"Voulgari","year":"2010","unstructured":"Voulgari C, Moyssakis I, Papazafiropoulou A et al (2010) The impact of metabolic syndrome on left ventricular myocardial performance. Diabetes Metab Res Rev 26:121\u2013127","journal-title":"Diabetes Metab Res Rev"},{"key":"3720_CR29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0008-6363(98)00233-8","volume":"42","author":"Paternostro","year":"1999","unstructured":"Paternostro G, Pagano D, Gnecchi-Ruscone T et al (1999) Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res 42:246\u2013253","journal-title":"Cardiovasc Res"},{"key":"3720_CR30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1056-8727(99)00039-2","volume":"13","author":"Malone","year":"1999","unstructured":"Malone JI, Schocken DD, Morrison AD, Gilbert-Barness E (1999) Diabetic cardiomyopathy and carnitine deficiency. J Diabetes Complications 13:86\u201390","journal-title":"J Diabetes Complications"},{"key":"3720_CR31","first-page":"375","volume":"110","author":"Sunni","year":"1986","unstructured":"Sunni S, Bishop SP, Kent SP, Geer JC (1986) Diabetic cardiomyopathy. A morphological study of intramyocardial arteries. Arch Pathol Lab Med 110:375\u2013381","journal-title":"Arch Pathol Lab Med"},{"key":"3720_CR32","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1210\/jc.86.6.2769","volume":"86","author":"Manzella","year":"2001","unstructured":"Manzella D, Barbieri M, Rizzo MR et al (2001) Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. J Clin Endocrinol Metab 86:2769\u20132774","journal-title":"J Clin Endocrinol Metab"},{"key":"3720_CR33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1520-7560(200003\/04)16:2<106::AID-DMRR88>3.0.CO;2-H","volume":"16","author":"Garay-Sevilla","year":"2000","unstructured":"Garay-Sevilla ME, Nava LE, Malacara JM et al (2000) Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 16:106\u2013113","journal-title":"Diabetes Metab Res Rev"},{"key":"3720_CR34","doi-asserted-by":"crossref","unstructured":"Seferovic PM, Ristic AD, Maksimovic R (2002) Progression of myocarditis to dilated cardiomyopathy: Role of the adrenergic system and myocardial catecholamines. In: Cooper L (ed) Myocarditis: from bench to bedside, Humana, New Jersey p\u00a0215\u2013230","DOI":"10.1385\/1-59259-319-4:215"},{"key":"3720_CR35","first-page":"1677","volume":"38","author":"Kurata","year":"1997","unstructured":"Kurata C, Okayama K, Wakabayashi Y et al (1997) Cardiac sympathetic neuropathy and effects of aldose reductase inhibitor in streptozocin-induced diabetic rats. J Nucl Med 38:1677\u20131680","journal-title":"J Nucl Med"},{"key":"3720_CR36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.CIR.98.10.961","volume":"98","author":"Stevens","year":"1998","unstructured":"Stevens MJ, Raffel DM, Allman KC et al (1998) Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation 98:961\u2013968","journal-title":"Circulation"},{"key":"3720_CR37","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","volume":"101","author":"Devereux","year":"2000","unstructured":"Devereux RB, Roman MJ, Paranicas M et al (2000) Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101:2271\u20132276","journal-title":"Circulation"},{"key":"3720_CR38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/hrt.2006.114082","volume":"94","author":"Maciver","year":"2008","unstructured":"Maciver DH, Townsend M (2008) A novel mechanism of heart failure with normal ejection fraction. Heart 94:446\u2013449","journal-title":"Heart"},{"key":"3720_CR39","doi-asserted-by":"crossref","unstructured":"Tsch\u00f6pe C, Lam CSP (2012) Diastolic heart failure: what we still don\u2019t know? Looking for new concepts, diagnostic approaches and the role of co-morbidities. Herz (Verlag bitte einsetzen)","DOI":"10.1007\/s00059-012-3719-5"},{"key":"3720_CR40","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00059-004-2626-9","volume":"29","author":"Pankuweit","year":"2004","unstructured":"Pankuweit S, Ruppert V, Maisch B (2004) Inflammation in dilated cardiomyopathy. Herz 29(8):788\u2013793","journal-title":"Herz"},{"key":"3720_CR41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.numecd.2008.04.001","volume":"19","author":"Simone","year":"2009","unstructured":"Simone G de, Devereux RB, Chinali M et al (2009) Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the strong heart study. Nutr Metab Cardiovasc Dis 19:98\u2013104","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3720_CR42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","volume":"117","author":"Van","year":"2008","unstructured":"Van Heerebeek L, Hamdani N, Handoko ML et al (2008) Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 117:43\u201351","journal-title":"Circulation"},{"key":"3720_CR43","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/j.1582-4934.2008.00547.x","volume":"13","author":"Ma","year":"2009","unstructured":"Ma H, Li AY, Xu P et al (2009) Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) upregulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med 13(8B):1751\u20131764","journal-title":"J Cell Mol Med"},{"key":"3720_CR44","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2337\/diabetes.47.7.1114","volume":"47","author":"Giardino","year":"1998","unstructured":"Giardino I, Fard AK, Hatchell DL, Brownlee M (1998) Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 47(7):1114\u20131120","journal-title":"Diabetes"},{"key":"3720_CR45","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000054165.93055.42","volume":"107","author":"Arnold","year":"2003","unstructured":"Arnold JM, Yusuf S, Young J et al (2003) Prevention of heart failure in patients in the Heart Outcome Prevention Evaluation (HOPE) study. Circulation 107:1284\u20131290","journal-title":"Circulation"},{"key":"3720_CR46","doi-asserted-by":"crossref","unstructured":"Seferovic PM, Ristic A, Maksimovic R et al (2003) The natural history of viral myocarditis: pathogenetic role of adrenergic system dysfunction in the development of idiopathic dilated cardiomyopathy. In: Matsumori A (ed) Cardiomyopathies and heart failure: biomolecular, infectious and immune mechanisms, Kluwer Academic Publishers, Dordrecht, p\u00a0358\u2013372","DOI":"10.1007\/978-1-4419-9264-2_27"},{"key":"3720_CR47","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.98.20.2180","volume":"98","author":"Russell","year":"1998","unstructured":"Russell RR, Yin R, Caplan MJ et al (1998) Additive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo. Circulation 98:2180\u20132186","journal-title":"Circulation"},{"key":"3720_CR48","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.CIR.98.10.961","volume":"98","author":"Stevens","year":"1998","unstructured":"Stevens MJ, Raffel DM, Allman KC et al (1998) Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation 98:961\u2013968","journal-title":"Circulation"},{"key":"3720_CR49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1081\/CEH-120019148","volume":"25","author":"Nakano","year":"2003","unstructured":"Nakano S, Kitazawa M, Ito T, Hatakeyama H et al (2003) Insulin resistant state in type 2 diabetes is related to advanced autonomic neuropathy. Clin Exp Hypertens 25:155\u2013167","journal-title":"Clin Exp Hypertens"},{"key":"3720_CR50","doi-asserted-by":"crossref","unstructured":"Maisch B, Rupp H. Myocardial fibrosis: a cardiopathophysiologic Janus head. Herz 2006;31(3):260\u2013268","DOI":"10.1007\/s00059-006-2823-9"},{"key":"3720_CR51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000064682","volume":"98","author":"Schannwell","year":"2002","unstructured":"Schannwell CM, Schneppenheim M, Perings S et al (2002) Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98:33\u201339","journal-title":"Cardiology"},{"key":"3720_CR52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s001250050928","volume":"41","author":"Ziegler","year":"1998","unstructured":"Ziegler D, Weise F, Langen KJ et al (1998) Effect of glycaemic control on myocardial sympathetic innervation assessed by (123I) metaiodo-benzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia 41:443\u2013451","journal-title":"Diabetologia"},{"key":"3720_CR53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<57::AID-DIA297>3.0.CO;2-7","volume":"14","author":"Schnell","year":"1997","unstructured":"Schnell O, Muhr D, Dresel S et al (1997) Partial restoration of scintigraphically assessed cardiac sympatethic denervation in newly diagnosed patients with insulin dependent (type 1) diabetes mellitus at one-year follow-up. Diabet Med 14:57\u201362","journal-title":"Diabet Med"},{"key":"3720_CR54","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2337\/diabetes.51.10.3077","volume":"51","author":"Hansen","year":"2002","unstructured":"Hansen A, Johansson BL, Wahren J, Bibra H von (2002) C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 51:3077\u20133082","journal-title":"Diabetes"},{"key":"3720_CR55","doi-asserted-by":"crossref","first-page":"E658","DOI":"10.1152\/ajpendo.00003.2002","volume":"283","author":"Norby","year":"2002","unstructured":"Norby FL, Wold LE, Duan J, Hintz KK, Ren J (2002) IGF-1 attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab 283:E658\u2013E666","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3720_CR56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00059-006-2805-y","volume":"31","author":"Maisch","year":"2006","unstructured":"Maisch B (2006) Obesity, diabetes mellitus and metabolic syndrome: the implications for heart and the vascular system. Herz 31(3):185\u2013188","journal-title":"Herz"},{"key":"3720_CR57","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/ajhp\/59.suppl_9.S3","volume":"59","author":"Stolar","year":"2002","unstructured":"Stolar MW (2002) Insulin resistance, diabetes, and the adipocyte. Am J Health Syst Pharm 59(Suppl 9):S3\u2013S8","journal-title":"Am J Health Syst Pharm"},{"key":"3720_CR58","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1210\/jc.2002-021786","volume":"88","author":"Pavo","year":"2003","unstructured":"Pavo I, Jermendy G, Varkonyi TT et al (2003) Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes. J Clin Endocrinol Metab 88:1637\u20131645","journal-title":"J Clin Endocrinol Metab"},{"key":"3720_CR59","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/01.CIR.0000139340.88769.D5","volume":"110","author":"Taegtmeyer","year":"2004","unstructured":"Taegtmeyer H (2004) Cardiac metabolism as a target for the treatment of heart failure. Circulation 110:894\u2013896","journal-title":"Circulation"},{"key":"3720_CR60","doi-asserted-by":"crossref","unstructured":"Hammer S, Meer RW van der, Lamb HJ et al (2008) Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 90413","DOI":"10.1152\/ajpendo.90413.2008"},{"key":"3720_CR61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1006882805197","volume":"180","author":"Rodrigues","year":"1998","unstructured":"Rodrigues B, Camm MC, Mcneill GH (1998) Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 180:53\u201357","journal-title":"Mol Cell Biochem"},{"key":"3720_CR62","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1152\/jappl.1995.78.1.76","volume":"78","author":"Hall","year":"1995","unstructured":"Hall JL, Sexton WL, Stanley WC (1995) Exercise training attenuates the reduction of myocardial GLUT-4 in diabetic rats. J Appl Physiol 78:76\u201381","journal-title":"J Appl Physiol"},{"key":"3720_CR63","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1152\/jappl.1997.82.3.828","volume":"82","author":"Osborn","year":"1997","unstructured":"Osborn BA, Daar JT, Laddaga RA et al (1997) Exercise training increases sarcolemmal GLUT-4 protein and mRNA content in diabetic heart. J Appl Physiol 82:828\u2013834","journal-title":"J Appl Physiol"},{"key":"3720_CR64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3181\/00379727-203-43593","volume":"203","author":"DeBlieux","year":"1993","unstructured":"DeBlieux PM, Barbee RW, McDonough KH, Shepard RE (1993) Exercise training improves cardiac performance in diabetic rats. Proc Soc Exp Biol Med 203:209\u2013213","journal-title":"Proc Soc Exp Biol Med"},{"key":"3720_CR65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacc.2007.10.009","volume":"51","author":"Ramasubbu","year":"2008","unstructured":"Ramasubbu K, Estep J, White DL et al (2008) Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol 51(4):415\u2013426","journal-title":"J Am Coll Cardiol"},{"key":"3720_CR66","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","volume":"357","author":"Kjekshus","year":"2007","unstructured":"Kjekshus J, Apetrei E, Barrios V et al (2007) Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357(22):2248\u20132261 (see comment)","journal-title":"N Engl J Med"},{"key":"3720_CR67","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Erratum appears in Lancet 1999;354(9178):602. Lancet 352(9131):837\u2013853","journal-title":"Lancet"},{"key":"3720_CR68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurjhf\/hfn018","volume":"11","author":"Jarnert","year":"2009","unstructured":"Jarnert C, Landstedt-Hallin L, Malmberg K et al (2009) A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes mellitus and Diastolic Dysfunction) study. Eur J Heart Fail 11(1):39\u201347","journal-title":"Eur J Heart Fail"},{"key":"3720_CR69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","volume":"26","author":"Flather","year":"2005","unstructured":"Flather MD, Shibata MC, Coats AJ et al (2005) Randomised trial to deter-mine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26:215\u2013225","journal-title":"Eur Heart J"},{"key":"3720_CR70","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","volume":"357","author":"The","year":"2001","unstructured":"The Capricorn Investigators (2001) Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the Capricorn randomized study. Lancet 357:1385\u20131390","journal-title":"Lancet"},{"key":"3720_CR71","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1464-5491.2007.02151.x","volume":"24","author":"Fonseca","year":"2007","unstructured":"Fonseca V, Bakris GL, Bell DS et al (2007) GEMINI Investigators. Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI. Diabet Med 24:759\u2013763","journal-title":"Diabet Med"},{"key":"3720_CR72","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.amjcard.2010.02.018","volume":"106","author":"Boer","year":"2010","unstructured":"Boer RA de, Doehner W, Horst IC van der SENIORS Investigators et al (2010) Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or = 70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]). Am J Cardiol 106(1):78\u201386","journal-title":"Am J Cardiol"},{"key":"3720_CR73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J et al (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145\u2013153","journal-title":"N Engl J Med"},{"key":"3720_CR74","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1053\/euhj.2002.3388","volume":"23","author":"Arbustini","year":"2002","unstructured":"Arbustini E, Cecchi F, Seferovic PM et al (2002) The need for European Registries in inherited cardiomyopathies. Eur Heart J 23(24):1972\u20131974","journal-title":"Eur Heart J"},{"key":"3720_CR75","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/eurheartj\/ehl337","volume":"27","author":"Mitrovic","year":"2006","unstructured":"Mitrovic V, Seferovic PM, Simeunovic D et al (2006) Haemodynamic and clinical effects of ularitide in decompensated heart failure. Eur Heart J 27(23):2823\u20132832","journal-title":"Eur Heart J"},{"key":"3720_CR76","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1067\/mhj.2003.161","volume":"145","author":"Mitrovic","year":"2003","unstructured":"Mitrovic V, Willenbrock R, Seferovic PM et al (2003) Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neuro-hormones, and clinical symptoms in patients with congestive heart failure. Am Heart J 145(3):E14","journal-title":"Am Heart J"},{"key":"3720_CR77","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.HYP.37.4.1053","volume":"37","author":"Sowers","year":"2001","unstructured":"Sowers JR, Epstein M, Frohlich ED (2001) Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 37:1053\u20131059","journal-title":"Hypertension"},{"key":"3720_CR78","first-page":"R332","volume":"277","author":"Henriksen","year":"1999","unstructured":"Henriksen EJ, Jacob S, Kinnikck TR et al (1999) ACE inhibition and glucose transport in insulin resist-ant muscle: roles of bradykinin and nitric oxide. Am J Physiol 277:R332\u2013R336","journal-title":"Am J Physiol"},{"key":"3720_CR79","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11906-004-0010-z","volume":"6","author":"Hermann","year":"2004","unstructured":"Hermann F, Ruschitzka FT, Schiffrin EL (2004) Clinical trials report. CHARM-Preserved Trial. Curr Hypertens Rep 6(1):48\u201350 (No abstract available)","journal-title":"Curr Hypertens Rep"},{"key":"3720_CR80","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.109.909614","volume":"121","author":"Zile","year":"2010","unstructured":"Zile MR, Gaasch WH, Anand IS et al (2010) Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation 121(12):1393\u20131405","journal-title":"Circulation"},{"key":"3720_CR81","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1753944708091777","volume":"2","author":"Werner","year":"2008","unstructured":"Werner CM, Bohm M (2008) Review: the therapeutic role of RAS blockade in chronic heart failure. Ther Adv Cardiovasc Dis 2(3):167\u2013177","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"3720_CR82","doi-asserted-by":"crossref","first-page":"H912","DOI":"10.1152\/ajpheart.00824.2006","volume":"292","author":"Yaras","year":"2007","unstructured":"Yaras N, Bilginoglu A, Vassort G et al (2007) Restoration of diabetes-induced abnormal local Ca2\u00fe release in cardiomyocytes by angiotensin II receptor blockade. Am J Physiol Heart Circ Physiol 292(2):H912\u2013H920","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3720_CR83","first-page":"E453","volume":"256","author":"Afzal","year":"1989","unstructured":"Afzal N, Pierce GN, Elimban V et al (1989) Influence of verapamil on some subcellular defects in diabetic cardiomyopathy. Am J Physiol 256:E453\u2013E458","journal-title":"Am J Physiol"},{"key":"3720_CR84","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00005344-199507000-00002","volume":"26","author":"Shah","year":"1995","unstructured":"Shah TS, Satia MC, Gandhi TP et al (1995) Effects of chronic nifedipine treatment on streptozocin-induced diabetic rats. J Cardiovasc Pharmacol 26:6\u201312","journal-title":"J Cardiovasc Pharmacol"},{"key":"3720_CR85","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/HCO.0b013e3283031ab3","volume":"23","author":"Pieske","year":"2008","unstructured":"Pieske BA, Wachter RB (2008) Impact of diabetes and hypertension on the heart. Current Opinion in Cardiology 23(4):340\u2013349","journal-title":"Current Opinion in Cardiology"},{"key":"3720_CR86","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/hrt.2007.128769","volume":"94","author":"Tribouilloy","year":"2008","unstructured":"Tribouilloy C, Rusinaru D, Mahjoub H et al (2008) Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective 5-year study. Heart 94(11):1450\u20131455","journal-title":"Heart"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-012-3720-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-012-3720-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-012-3720-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T13:14:33Z","timestamp":1562418873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-012-3720-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":86,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3720"],"URL":"https:\/\/doi.org\/10.1007\/s00059-012-3720-z","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}